We evaluated the impact of noninvasive respiratory support (NRS) and invasive mechanical ventilation duration before venovenous extracorporeal membrane oxygenation (VV-ECMO) on weaning from venovenous ECMO and survival.
Methods:
In a retrospective single-center study, we studied subjects with COVID-19 ARDS treated with VV-ECMO. The subjects were divided and analyzed according to the cut-off of NRS, invasive ventilation, and total duration of respiratory support.
Results:
We identified a cut-off of NRS duration of 4 days, invasive ventilation duration of 5 days, and total respiratory support duration of 8 days. Weaning from VV-ECMO was observed in 63% (15/24) of subjects with NRS duration ≤ 4 days and in 16% (4/25) of subjects with NRS > 4 days (P = .001), in 50% (17/34) of subjects with invasive ventilation duration ≤ 5 days, in 13% (2/15) of subjects with invasive ventilation duration > 5 days (P = .02), in 68% (13/19) of subjects with total support duration < 8 days, and in 20% (6/30) of subjects with total support duration > 8 days (P = .001). The survival probability at 200 days demonstrated a statistically significant difference in NRS and total support duration comparison (P = .001 and P = .004, respectively). We did not find a statistically significant survival difference according to invasive ventilation duration (P = .13).
Conclusions:
In our population, the increase in NRS and total support days before ECMO could hamper weaning from VV-ECMO support. However, due to the pandemic, the small sample size, and the lack of precise data on ventilation settings, caution should be exercised in universalizing these results.
Get full access to this article
View all access options for this article.
References
1.
HasanSS, CapstickT, AhmedR, et al.Mortality in COVID-19 patients with acute respiratory distress syndrome and corticosteroids use: a systematic review and meta-analysis. Expert Rev Respir Med, 2020; 14(11):1149–1163; doi: 10.1080/17476348.2020.1804365
2.
ChiumelloD, ModafferiL, FrattiI. Risk factors and mortality in elderly ARDS COVID-19 compared to patients without COVID-19. J Clin Med, 2022; 11(17):5180; doi: 10.3390/jcm11175180
3.
CammarotaG, EspositoT, AzzolinaD, et al.Noninvasive respiratory support outside the intensive care unit for acute respiratory failure related to coronavirus-19 disease: a systematic review and meta-analysis. Crit Care, 2021; 25(1):268; doi: 10.1186/s13054-021-03697-0
4.
SchünemannHJ, KhabsaJ, SoloK, et al.Ventilation techniques and risk for transmission of coronavirus disease, including COVID-19: A living systematic review of multiple streams of evidence. Ann Intern Med, 2020; 173(3):204–216; doi: 10.7326/M20-2306
5.
SullivanZP, ZazzeronL, BerraL, et al.Noninvasive respiratory support for COVID-19 patients: when, for whom, and how? J Intensive Care, 2022; 10(1):3; doi: 10.1186/s40560-021-00593-1
GattinoniL, MariniJJ, BusanaM, et al.Spontaneous breathing, transpulmonary pressure and mathematical trickery. Ann Intensive Care, 2020; 10(1):88; doi: 10.1186/s13613-020-00708-1
8.
MinaB, NewtonA, HaddaV. Noninvasive ventilation in treatment of respiratory failure-related COVID-19 infection: review of the literature. Can Respir J, 2022; 2022:9914081; doi: 10.1155/2022/9914081
9.
TobinMJ, LaghiF, JubranA. Caution about early intubation and mechanical ventilation in COVID-19. Ann Intensive Care, 2020; 10(1):78; doi: 10.1186/s13613-020-00692-6
10.
PeekGJ, MugfordM, TiruvoipatiR, et al.; CESAR trial collaboration. Efficacy and economic assessment of conventional ventilatory support versus extracorporeal membrane oxygenation for severe adult respiratory failure (CESAR): a multicentre randomised controlled trial. Lancet, 2009; 374(9698):1351–1363; doi: 10.1016/S0140-6736(09)61069-2
11.
CombesA, HajageD, CapellierG, et al.; EOLIA Trial Group, REVA, and ECMONet. Extracorporeal membrane oxygenation for severe acute respiratory distress syndrome. N Engl J Med, 2018; 378(21):1965–1975; doi: 10.1056/NEJMoa1800385
12.
CombesA, PeekGJ, HajageD, et al.ECMO for severe ARDS: systematic review and individual patient data meta-analysis. Intensive Care Med, 2020; 46(11):2048–2057; doi: 10.1007/s00134-020-06248-3
13.
AlessandriF, Di NardoM, RamanathanK, et al.Extracorporeal membrane oxygenation for COVID-19-related acute respiratory distress syndrome: a narrative review. J Intensive Care, 2023; 11(1):5; doi: 10.1186/s40560-023-00654-7
14.
BertiniP, GuarracinoF, FalconeM, et al.ECMO in COVID-19 patients: a systematic review and meta-analysis. J Cardiothorac Vasc Anesth, 2022; 36(8 Pt A):2700–2706; doi: 10.1053/j.jvca.2021.11.006
15.
BartlettRH, OginoMT, BrodieD, et al.Initial ELSO guidance document: ECMO for COVID-19 patients with severe cardiopulmonary failure. Asaio J, 2020; 66(5):472–474; doi: 10.1097/MAT.0000000000001173
16.
BadulakJ, AntoniniMV, SteadCM, et al; ELSO COVID-19 Working Group Members. Extracorporeal membrane oxygenation for COVID-19: updated 2021 guidelines from the extracorporeal life support organization. Asaio J, 2021; 67(5):485–495; doi: 10.1097/MAT.0000000000001422
17.
AhmadQ, GreenA, ChandelA, et al.Impact of noninvasive respiratory support in patients With COVID-19 Requiring V-V ECMO. Asaio J, 2022; 68(2):171–177; doi: 10.1097/MAT.0000000000001626
18.
GianiM, MaggioliniD, AmbrosettiL, et al.Prolonged noninvasive respiratory support before intubation is associated with increased duration of extracorporeal membrane oxygenation. Asaio J, 2023; 69(3):e118–e120; doi: 10.1097/MAT.0000000000001810
19.
Fuset-CabanesMP, Hernández-PlateroLL, Sabater-RieraJ, et al.Days spent on non-invasive ventilation support: can it determine when to initiate VV-ECMO? Observational study in a cohort of Covid-19 patients. BMC Pulm Med, 2023; 23(1):310; doi: 10.1186/s12890-023-02605-2
20.
YoudenWJ. Index for rating diagnostic tests. Cancer, 1950; 3(1):32–35; doi: 10.1002/1097-0142(1950)3:1<32::aid-cncr2820030106>3.0.co;2-3
21.
LazzeriC, BonizzoliM, BatacchiS, et al.Right ventricle dysfunction does not predict mortality in patients with SARS-CoV-2-related acute respiratory distress syndrome on extracorporeal membrane oxygenation support. World J Cardiol, 2023; 15(4):165–173; doi: 10.4330/wjc.v15.i4.165
BrowerRG, MatthayMA, MorrisA, et al; Acute Respiratory Distress Syndrome Network. Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. N Engl J Med, 2000; 342(18):1301–1308; doi: 10.1056/NEJM200005043421801
24.
AmatoMBP, MeadeMO, SlutskyAS, et al.Driving pressure and survival in the acute respiratory distress syndrome. N Engl J Med, 2015; 372(8):747–755; doi: 10.1056/NEJMsa1410639
25.
GattinoniL, TonettiT, CressoniM, et al.Ventilator-related causes of lung injury: the mechanical power. Intensive Care Med, 2016; 42(10):1567–1575; doi: 10.1007/s00134-016-4505-2
26.
TonnaJE, AbramsD, BrodieD, et al.Management of adult patients supported with Venovenous Extracorporeal Membrane Oxygenation (VV ECMO): Guideline from the Extracorporeal Life Support Organization (ELSO). Asaio J, 2021; 67(6):601–610; doi: 10.1097/MAT.0000000000001432
27.
SchmidtM, BaileyM, SheldrakeJ, et al.Predicting survival after extracorporeal membrane oxygenation for severe acute respiratory failure. The Respiratory Extracorporeal Membrane Oxygenation Survival Prediction (RESP) score. Am J Respir Crit Care Med, 2014; 189(11):1374–1382; doi: 10.1164/rccm.201311-2023OC
28.
SchmidtM, ZogheibE, RozéH, et al.The PRESERVE mortality risk score and analysis of long-term outcomes after extracorporeal membrane oxygenation for severe acute respiratory distress syndrome. Intensive Care Med, 2013; 39(10):1704–1713; doi: 10.1007/s00134-013-3037-2
29.
BellaniG, LaffeyJG, PhamT, et al.; ESICM Trials Group. Noninvasive ventilation of patients with acute respiratory distress syndrome. Insights from the LUNG SAFE study. Am J Respir Crit Care Med, 2017; 195(1):67–77; doi: 10.1164/rccm.201606-1306OC
30.
YoshidaT, FujinoY, AmatoMBP, et al.Fifty years of research in ARDS. Spontaneous breathing during mechanical ventilation. Risks, mechanisms, and management. Am J Respir Crit Care Med, 2017; 195(8):985–992; doi: 10.1164/rccm.201604-0748CP
31.
YoshidaT, TorsaniV, GomesS, et al.Spontaneous effort causes occult pendelluft during mechanical ventilation. Am J Respir Crit Care Med, 2013; 188(12):1420–1427; doi: 10.1164/rccm.201303-0539OC
32.
WeerakkodyS, ArinaP, GlenisterJ, et al.Non-invasive respiratory support in the management of acute COVID-19 pneumonia: considerations for clinical practice and priorities for research. Lancet Respir Med, 2022; 10(2):199–213; doi: 10.1016/S2213-2600(21)00414-8
33.
GriecoDL, MengaLS, CesaranoM, et al.; COVID-ICU Gemelli Study Group. Effect of helmet noninvasive ventilation vs high-flow nasal oxygen on days free of respiratory support in patients with COVID-19 and moderate to severe hypoxemic respiratory failure: The HENIVOT Randomized Clinical Trial. Jama, 2021; 325(17):1731–1743; doi: 10.1001/jama.2021.4682
34.
PerkinsGD, JiC, ConnollyBA, et al.; RECOVERY-RS Collaborators. Effect of noninvasive respiratory strategies on intubation or mortality among patients with acute hypoxemic respiratory failure and COVID-19: The RECOVERY-RS Randomized Clinical Trial. Jama, 2022; 327(6):546–558; doi: 10.1001/jama.2022.0028
ManriqueS, ClaveriasL, MagretM, et al.Timing of intubation and ICU mortality in COVID-19 patients: a retrospective analysis of 4198 critically ill patients during the first and second waves. BMC Anesthesiol, 2023; 23(1):140; doi: 10.1186/s12871-023-02081-5
37.
GarfieldBE, BianchiP, ArachchillageDJ, et al.A comparison of long-term outcomes in patients managed with venovenous extracorporeal membrane oxygenation in the first and second waves of the COVID-19 Pandemic in the United Kingdom. Crit Care Med, 2023; 51(8):1064–1073; doi: 10.1097/CCM.0000000000005864
38.
SchmidtM, HajageD, LandollM, et al; ECMO-SURGES Investigators. Comparative outcomes of extracorporeal membrane oxygenation for COVID-19 delivered in experienced European centres during successive SARS-CoV-2 variant outbreaks (ECMO-SURGES): an international, multicentre, retrospective cohort study. Lancet Respir Med, 2023; 11(2):163–175; doi: 10.1016/S2213-2600(22)00438-6
39.
GrotbergJC, KraftBD, SullivanM, et al.Advanced respiratory support days as a novel marker of mortality in COVID-19 acute respiratory distress syndrome requiring extracorporeal membrane oxygenation. Asaio J, 2024; 70(5):427–435; doi: 10.1097/MAT.0000000000002119
40.
TonelliR, FantiniR, TabbìL, et al.Early inspiratory effort assessment by esophageal manometry predicts noninvasive ventilation outcome in de novo respiratory failure. a pilot study. Am J Respir Crit Care Med, 2020; 202(4):558–567; doi: 10.1164/rccm.201912-2512OC
41.
GriecoDL, MaggioreSM, RocaO, et al.Non-invasive ventilatory support and high-flow nasal oxygen as first-line treatment of acute hypoxemic respiratory failure and ARDS. Intensive Care Med, 2021; 47(8):851–866; doi: 10.1007/s00134-021-06459-2
42.
PatelBK, WolfeKS, PohlmanAS, et al.Effect of noninvasive ventilation delivered by helmet vs face mask on the rate of endotracheal intubation in patients with acute respiratory distress syndrome: A Randomized Clinical Trial. Jama, 2016; 315(22):2435–2441; doi: 10.1001/jama.2016.6338
43.
GattinoniL, MariniJJ. Isn’t it time to abandon ARDS? The COVID-19 lesson. Crit Care, 2021; 25(1):326; doi: 10.1186/s13054-021-03748-6
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
